StockData
Revelation Biosciences, Inc. logo

Revelation Biosciences, Inc. (REVB) stock

REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.88+0.06 (+1.57%)

Close on Nov 17, 2026Market cap $15.46MP/E –Yield –

Revelation Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Revelation Biosciences's price to book ratio was 1.7× on Nov 11, 2026, against 8.7× a year earlier. Over the last 2 years it ranged from 0.2× to 447.1×, with a median of 7.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−5.6
2025Dec 31, 20257.3×−375.0
2024Jul 31, 2024382.3×–

More Revelation Biosciences figures

See a number that looks wrong?